BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37376735)

  • 1. Risk factors for prostate-specific antigen persistence in pT3aN0 prostate cancer after robot-assisted laparoscopic radical prostatectomy: a retrospective study.
    Kim JS; Chung JH; Song W; Kang M; Sung HH; Jeon HG; Jeong BC; Seo SI; Lee HM; Jeon SS
    J Yeungnam Med Sci; 2023 Oct; 40(4):412-418. PubMed ID: 37376735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphovascular invasion is an independent predictor of prostate-specific antigen failure after radical prostatectomy in patients with pT3aN0 prostate cancer.
    Yamamoto S; Kawakami S; Yonese J; Fujii Y; Ohkubo Y; Suyama T; Komai Y; Kijima T; Ishikawa Y; Fukui I
    Int J Urol; 2008 Oct; 15(10):895-9. PubMed ID: 18721204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A risk grouping algorithm for predicting factors of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
    Micoogullari U; Cakici MC; Kisa E; Canda AE; Kilic FU; Ardicoglu A; Altinova S; Atmaca AF; Akbulut Z; Balbay MD
    Int J Clin Pract; 2021 Oct; 75(10):e14495. PubMed ID: 34155724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Variations in Prostatic Apex Shape on Apical Margin Positive Rate After Radical Prostatectomy: Robot-Assisted Laparoscopic Radical Prostatectomy vs Open Radical Prostatectomy.
    Yu YD; Lee M; Hong SK; Byun SS; Lee SE; Lee S
    J Endourol; 2018 Jan; 32(1):46-53. PubMed ID: 29212368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
    Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
    J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of prostate-specific antigen recurrence-free survival in a contemporary cohort of patients undergoing either radical retropubic or robot-assisted laparoscopic radical prostatectomy.
    Schroeck FR; Sun L; Freedland SJ; Albala DM; Mouraviev V; Polascik TJ; Moul JW
    BJU Int; 2008 Jul; 102(1):28-32. PubMed ID: 18384634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Analysis of Perioperative Outcomes on Neoadjuvant Hormone Therapy before Laparoscopic and Robot-Assisted Surgery for Localized High-Risk Prostate Cancer in a Chinese Cohort.
    Sun G; Liang Z; Jiang Y; Ma S; Chen S; Liu R
    Curr Oncol; 2022 Nov; 29(11):8668-8676. PubMed ID: 36421336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncologic Outcomes Following Robot-Assisted Radical Prostatectomy for Clinical T3 Prostate Disease.
    Zilberman DE; Abu-Ghanem Y; Raviv G; Rosenzweig B; Fridman E; Portnoy O; Dotan ZA
    Isr Med Assoc J; 2021 Feb; 23(2):111-115. PubMed ID: 33595217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robotic radical prostatectomy as the initial step in multimodal therapy for men with high-risk localised prostate cancer: initial experience of 160 men.
    Connolly SS; Cathcart PJ; Gilmore P; Kerger M; Crowe H; Peters JS; Murphy DG; Costello AJ
    BJU Int; 2012 Mar; 109(5):752-9. PubMed ID: 21992472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for short-term biochemical recurrence-free survival after robot-assisted laparoscopic radical prostatectomy in high-risk prostate cancer patients.
    Kanehira M; Takata R; Ishii S; Ito A; Ikarashi D; Matsuura T; Kato Y; Obara W
    Int J Clin Oncol; 2019 Sep; 24(9):1099-1104. PubMed ID: 30972506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors and the important role of detectable prostate-specific antigen for detection of clinical recurrence and cancer-specific mortality following robot-assisted radical prostatectomy.
    García-Barreras S; Rozet F; Nunes-Silva I; Srougi V; Sanchez-Salas R; Barret E; Galiano M; Cathelineau X
    Clin Transl Oncol; 2018 Aug; 20(8):1004-1010. PubMed ID: 29243074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical prostatectomy in T4 prostate cancer after inductive androgen deprivation: results of a single-institution series with long-term follow-up.
    Hajili T; Ohlmann CH; Linxweiler J; Niklas C; Janssen M; Siemer S; Stoeckle M; Saar M
    BJU Int; 2019 Jan; 123(1):58-64. PubMed ID: 29772100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition and preoperative predictors of persistently elevated prostate-specific antigen after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Moreira DM; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ
    BJU Int; 2010 Jun; 105(11):1541-7. PubMed ID: 19912191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting surgical margin positivity in robotic assisted radical prostatectomy.
    Yuksel M; Karamık K; Anıl H; Islamoglu E; Ates M; Savas M
    Arch Ital Urol Androl; 2017 Mar; 89(1):71-74. PubMed ID: 28403595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer: 8-Year Follow-up.
    Lantz A; Bock D; Akre O; Angenete E; Bjartell A; Carlsson S; Modig KK; Nyberg M; Kollberg KS; Steineck G; Stranne J; Wiklund P; Haglind E
    Eur Urol; 2021 Nov; 80(5):650-660. PubMed ID: 34538508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of perineural invasion, lymphovascular invasion, and high-grade prostatic intraepithelial neoplasia in robot-assisted laparoscopic radical prostatectomy.
    Jung JH; Lee JW; Arkoncel FR; Cho NH; Yusoff NA; Kim KJ; Song JM; Kim SJ; Rha KH
    Ann Surg Oncol; 2011 Dec; 18(13):3828-32. PubMed ID: 21660497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy.
    Bravi CA; Droghetti M; Fossati N; Gandaglia G; Suardi N; Mazzone E; Cucchiara V; Scuderi S; Barletta F; Schiavina R; Osmonov D; Juenemann KP; Boeri L; Karnes RJ; Kretschmer A; Buchner A; Stief C; Hiester A; Nini A; Albers P; Devos G; Joniau S; Van Poppel H; Grubmüller B; Shariat SF; Heidenreich A; Pfister D; Tilki D; Graefen M; Gill IS; Mottrie A; Karakiewicz PI; Montorsi F; Briganti A
    Eur Urol Oncol; 2022 Jun; 5(3):285-295. PubMed ID: 34176768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.